Phage display screening identifies a prostate specific antigen (PSA)(–/lo) prostate cancer cell specific peptide to retard castration resistance of prostate cancer

Patients with prostate cancer (PCa) will eventually progress to castrate-resistant prostate cancer (CRPC) after androgen deprivation therapy (ADT) treatment. Prostate-specific antigen (PSA)(−)(/lo) cells which harbor self-renewing long-term tumor-propagating cells that can be enriched using ALDH+CD4...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Yi, Zhu, Rujian, Hu, Wei, Zhang, Wei, Zhu, Hongbo, Gong, Min, Gao, Lili, Cao, Ting, Tang, Tao, Yu, Bo, Yang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844130/
https://www.ncbi.nlm.nih.gov/pubmed/33508757
http://dx.doi.org/10.1016/j.tranon.2021.101020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844130/
https://www.ncbi.nlm.nih.gov/pubmed/33508757
http://dx.doi.org/10.1016/j.tranon.2021.101020

Ejemplares similares